GPR162 and neoplasm: The tumor volume of the control group was reduced by around 55% following radiotherapy, whereas the volume of the overexpression group was reduced by about 85%, implying that the overexpression GPR162 group was more susceptible to radiotherapy (Fig. 8e, f).